Vaccine’, a reputed peer-reviewed international journal, Publishes Phase-III Results of PNEUBEVAX 14TM BE-PCV-14 can be given safely to infants to prevent Pneumococcal Disease PNEUBEVAX 14TM induced robust & functional serotype specific immune response in infants to 14 serotypes offering broadest serotype coverage of any